Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 06 entities : Sanofi save search
BioNTech and Australia’s State of Victoria Form Strategic Partnership to Establish mRNA Research Center and Manufacturing Facility
Published: 2022-10-06 (Crawled : 00:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: -4.81%
H: 0.0%
C: -2.52%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
BNTX | News | $88.09 -0.45% -0.35% 1.9K
|
Health Technology
|
| O: -0.79%
H: 1.14%
C: -1.28%
partnership research state mrna
Autoimmune Hemolytic Anemia Therapeutics Market to Record a CAGR of 9.1%, Majority of Market Growth to Originate from North America - Technavio
Published: 2022-10-06 (Crawled : 23:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: -3.32%
H: 0.0%
C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: -4.81%
H: 0.0%
C: -2.52%
AZNCF | News | $135.35 -3.53% -4.19% 0
|
Health Technology
|
| O: 0.07%
H: 0.92%
C: 0.27%
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: -1.8%
BAX | $40.93 -0.22% 0.0% 3
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.48%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 1.55%
H: 0.79%
C: -0.65%
ARGX | $375.0 -0.02% -0.02% 0
|
Health Technology
|
| O: -3.19%
H: 0.91%
C: -0.99%
america anemia therapeutics growth market
Global Nanomedicine Market to Reach $433.9 Billion by 2027 at a 13.46% CAGR
Published: 2022-10-06 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: -4.81%
H: 0.0%
C: -2.52%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: -4.56%
H: 0.29%
C: 0.29%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.16%
H: 0.09%
C: -0.67%
GE | News | $159.19 -2.11% -0.62% 9.3M
|
Electronic Technology
|
| O: -0.92%
H: 0.25%
C: -1.6%
ABT | News | $106.89 -0.65% -0.09% 4.2M
|
Health Technology
|
| O: 0.05%
H: 2.53%
C: -0.69%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
global market
Lilly's Mounjaro is on the Fast Track Toward Potential Obesity Approval
Published: 2022-10-06 (Crawled : 16:00) - biospace.com/
MS | News 0 d | $93.85 0.1% -0.02% 3.3M
|
Finance
|
| O: -0.8%
H: 0.9%
C: -1.38%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
obesity approval potential
Anticipating FDA "Yes", Provention Inks Co-Promotion Deal with Sanofi for T1D Drug
Published: 2022-10-06 (Crawled : 16:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
fda drug deal sanofi
Anticipating FDA "Yes", Provention Inks Co-Promotion Deal with Sanofi for T1D...
Published: 2022-10-06 (Crawled : 15:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
fda deal sanofi
Anticoagulants Market is expected to generate a revenue of USD 56.16 Billion by 2028, Globally, at 10.20% CAGR: Verified Market Research®
Published: 2022-10-06 (Crawled : 14:20) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0
|
Health Technology
|
| O: -2.53%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.82%
H: 0.03%
C: -1.53%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: -1.25%
H: 0.53%
C: -0.1%
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: -0.92%
H: 0.06%
C: -0.78%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
research expected market
Framework Solutions Launches Medical Affairs Division with Appointment of Key Executive
Published: 2022-10-06 (Crawled : 13:00) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
solutions
Provention Bio to Combine Forces with Sanofi to Support Potential U.S. Launch of Teplizumab for Delay in Onset of Clinical Type 1 Diabetes (T1D) in At-Risk Individuals
Published: 2022-10-06 (Crawled : 12:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 24.09%
H: 0.0%
C: 0.0%
teplizumab diabetes potential sanofi
Sanofi US enters into co-promotion agreement with Provention Bio, Inc. to launch teplizumab, an investigational disease-modifying therapy for type 1 diabetes
Published: 2022-10-06 (Crawled : 12:00) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 24.09%
H: 0.0%
C: 0.0%
diabetes agreement therapy sanofi
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.